
Janice Mehnert, MD, medical oncologist, director, Phase I and Developmental Therapeutics Program, Rutgers Cancer Institute, discusses the challenges with finding biomarkers for immunotherapy agents.

Your AI-Trained Oncology Knowledge Connection!


Published: June 24th 2016 | Updated: